Loomis Sayles Small/Mid Cap Growth Instl holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Loomis Sayles Small/Mid Cap Growth Fund Institutional Class LSMIX
- NAV / 1-Day Return $15.79 / +0.96 %
- Fund Size $190.2M
- Adjusted Expense Ratio 0.850%
- Net Expense Ratio 0.850%
- Fee Level: Distribution Below Average
- Share Class Type Institutional
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $100,000
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 55%
Morningstar’s Analysis LSMIX
Will LSMIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 18.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Fixed Inc Clearing Corp.Repo | 2.76 | 6M | Cash and Equivalents |
Life Time Group Holdings Inc | 2.11 | 5M | Consumer Cyclical |
ATI Inc | 2.10 | 5M | Industrials |
Hinge Health Inc Ordinary Shares - Class A | 1.89 | 4M | Healthcare |
Repligen Corp | 1.86 | 4M | Healthcare |
Charles River Laboratories International Inc | 1.85 | 4M | Healthcare |
Glaukos Corp | 1.81 | 4M | Healthcare |
Enova International Inc | 1.79 | 4M | Financial Services |
Natera Inc | 1.78 | 4M | Healthcare |
Travere Therapeutics Inc Ordinary Shares | 1.76 | 4M | Healthcare |